![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Zhejiang East-asia Pharmaceutical Co., Ltd. Taizhou Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Levofloxacin hemihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2020-242 - Rev 01
This Chemical Type CEP, issued on June 22, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2598 associated with this CEP further emphasizes